A Mutant Type 2 Herpes Simplex Virus Deleted for the Protein Kinase Domain of the ICP10 Gene Is a Potent Oncolytic Virus

被引：0
|
作者：
Fu, Xinping [1 ,2 ]
Tao, Lihua [1 ]
Zhang, Xiaoliu [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.180
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
157
引用
收藏
页码：S61 / S62
页数：2
相关论文
共 50 条
  • [31] THE TRANSMEMBRANE HELICAL SEGMENT BUT NOT THE INVARIANT LYSINE IS REQUIRED FOR THE KINASE-ACTIVITY OF THE LARGE SUBUNIT OF HERPES-SIMPLEX VIRUS TYPE-2 RIBONUCLEOTIDE REDUCTASE (ICP10)
    LUO, JH
    AURELIAN, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (14) : 9645 - 9653
  • [32] ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
    Liu, BL
    Robinson, M
    Han, ZQ
    Branston, RH
    English, C
    Reay, P
    McGrath, Y
    Thomas, SK
    Thornton, M
    Bullock, P
    Love, CA
    Coffin, RS
    GENE THERAPY, 2003, 10 (04) : 292 - 303
  • [33] ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
    B L Liu
    M Robinson
    Z-Q Han
    R H Branston
    C English
    P Reay
    Y McGrath
    S K Thomas
    M Thornton
    P Bullock
    C A Love
    R S Coffin
    Gene Therapy, 2003, 10 : 292 - 303
  • [34] Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus
    Ushijima, Yoko
    Luo, Chenhong
    Goshima, Fumi
    Yamauchi, Yohei
    Kimura, Hiroshi
    Nishiyama, Yukihiro
    MICROBES AND INFECTION, 2007, 9 (02) : 142 - 149
  • [35] An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer
    Fu, X.
    Tao, L.
    Zhang, X.
    CANCER GENE THERAPY, 2007, 14 (05) : 480 - 487
  • [36] An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer
    X Fu
    L Tao
    X Zhang
    Cancer Gene Therapy, 2007, 14 : 480 - 487
  • [37] Construction and evaluation of tissue distribution of oncolytic herpes simplex virus type 2 expressing firefly gene
    Zou, Zongxing
    Wang, Yang
    Luo, Kailun
    Li, Yuying
    Jin, Jing
    Hu, Han
    Cai, Linkang
    Yang, Junhan
    Ke, Zonghuang
    Fang, Zongyao
    Zhang, Siqi
    Fang, Zhizheng
    Liu, Binlei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (04): : 1647 - 1658
  • [38] Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2
    Daikoku, T
    Shibata, S
    Goshima, F
    Oshima, S
    Tsurumi, T
    Yamada, H
    Yamashita, Y
    Nishiyama, Y
    VIROLOGY, 1997, 235 (01) : 82 - 93
  • [39] Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene
    Hata, S
    Koyama, AH
    Shiota, H
    Adachi, A
    Goshima, F
    Nishiyama, Y
    MICROBES AND INFECTION, 1999, 1 (08) : 601 - 607
  • [40] VACCINE POTENTIAL OF A HERPES-SIMPLEX VIRUS TYPE-1 MUTANT WITH AN ESSENTIAL GLYCOPROTEIN DELETED
    FARRELL, HE
    MCLEAN, CS
    HARLEY, C
    EFSTATHIOU, S
    INGLIS, S
    MINSON, AC
    JOURNAL OF VIROLOGY, 1994, 68 (02) : 927 - 932
12345